Practices of community pharmacists during the COVID-19 pandemic: potential barriers and views on providing pharmacy services in Thailand

Main Article Content

Narumol Jarernsiripornkul
Kamonphat Wongtaweepkij
Disorn Pason
Thanyaporn Namwan


community pharmacists, practices, barriers, attitudes, COVID-19 pandemic


Background: Community pharmacists have played an essential health service role during the Coronavirus Disease 2019 (COVID-19) outbreak. Practices of community pharmacists against the pandemic may differ based on the specific guidance and level of preparedness in each country. Objective: This study explored the roles of community pharmacists in disease prevention, the provision of counseling services, and the supply of medications and preventive devices as well as the potential barriers and attitudes of community pharmacists towards COVID-19 infection. Methods: This cross-sectional study was conducted over three months (December 2021- March 2022). Online self-administered questionnaires were distributed to the community pharmacists across Thailand. Results: Of the 835 questionnaires distributed, 339 were completed (40.6%). Almost all respondents provided alcohol sanitizers inside their pharmacies (99.1%) and advised patients about how to use Antigen Test Kits (ATK) and interpret their ATK results (98.5%). The majority of respondents also provided advice to customers about ATK screening (97.6%). Respondents in chain pharmacies were more likely to provide encouragement to customers to keep social distancing (p<0.01), use preventive devices (p=0.004), and provide telepharmacy consulting services (p<0.01). Concern about contracting COVID-19 while working was the most common barrier to providing care cited by respondents (77.6%). Respondents had positive overall attitudes towards providing COVID-related counseling and believed that training programs and information support were important to the provision of COVID-19 care (82.6% and 64.6% agreed with the respective statements). Conclusion: Our findings reveal good practices among Thai community pharmacists on providing pharmacy services during the pandemic. Information support and training programs about COVID-19 from the Thai health authorities should be developed to improve the quality of pharmacy service.

Abstract 100 | PDF Downloads 90


1. Mohan BS, Nambiar V. COVID-19: An insight into SARS-CoV2 pandemic originated at Wuhan City in Hubei Province of China. J Infect Dis Epidemiol. 2020;6:146.
2. Rahman HS, Aziz MS, Hussein RH, et al. The transmission modes and sources of COVID-19: a systematic review. Int J Surg Open. 2020;26:125-136. https://doi:10.1016/j.ijso.2020.08.017
3. World Health Organization (2021). COVID-19 Weekly Epidemiological Update - Published 31 August 2021. Available: pdf?sfvrsn=e33e80ba_7&download=true. Accessed 29 September 2021.
4. Ministry of Public Health (2021). COVID-19 report - 6 August 2021. Available: viralpneumonia/file/ situation/situation-no581-060864.pdf. Accessed 29 September 2021.
5. Department of Medical Services (2019). The Ministry of Public Health. Thailand National Clinical Practice Guidelines for Treatment of Coronavirus Disease 2019. Available: Content/Select_Landding_page?contentId=155. Accessed 29 September 2021.
6. Centers for Disease Control and Prevention (2021). CDC Updates and Shortens Recommended Isolation and Quarantine Period for General Population. Available: 2021/s1227-isolation-quarantine-guidance.html. Accessed 29 September 2021.
7. Tanwettiyanont J, Piriyachananusorn N, Sangsoi L, et al. Use of Andrographis paniculata (Burm.f.) Wall. ex Nees and risk of pneumonia in hospitalised patients with mild coronavirus disease 2019: a retrospective cohort study. Front Med. 2022;9:947373.
8. Jia X, Zhang W, Du S, et al. What is the role of pharmacists in treating COVID-19 patients? The experiences and expectations of front line medical staff. Front Public Heal. 2021;9:778863.
9. Federation International Pharmaceutical (2020). COVID-19: Guidelines for Pharmacists and the Pharmacy Workforce. Available: pdf. Accessed 29 September 2021.
10. Zheng SG, Yang L, Zhou PX, et al. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: a China perspective. Res Soc Adm Pharm. 2021;17(1):1819-1824.
11. Goode JVR, Page A, Burns A, et al. The pharmacist’s role in SARS-CoV-2 diagnostic testing. J Am Pharm Assoc (2003). 2020;60(6):e19-e32.
12. Amariles P, Ledezma-Morales M, et al. How to link patients with suspicious COVID-19 to health system from the community pharmacies? A route proposal. Res Soc Adm Pharm. 2021;17(1):1988-1989.
13. Ababneh BF, Ong SC, Mahmoud F, et al. Attitudes, awareness, and perceptions of general public and pharmacists toward the extended community pharmacy services and drive-thru pharmacy services: a systematic review. J Pharm Policy Pract. 2023;16(1):37.
14. Durand C, Douriez E, Chappuis A, et al. Contributions and challenges of community pharmacists during the COVID-19 pandemic: a qualitative study. J Pharm Policy Pract. 2022;15(1):43.
15. Wulandari LPL, Khan M, Probandari A,et al. “We face the same risk as the other health workers”: Perceptions and experiences of community pharmacists in Indonesia during the COVID-19 pandemic. PLOS Glob Public Heal. 2022;2(7):e0000606. https://
16. Cochran WG. Sampling techniques. 3rd ed. New York: John Wiley & Sons; 1977. 17. Novak H, Tadić I, Falamić S, et al. Pharmacists’ role, work practices, and safety measures against COVID-19: a comparative study. J Am Pharm Assoc. (2003) 2021;61(4):398-407.
18. Zeenny RM, Dimassi A, Sacre H, et al. A cross-sectional survey on community pharmacists readiness to fight COVID-19 in a developing country: knowledge, attitude, and practice in Lebanon. J Pharm Policy Pract. 2021;14(1):51. https://doi. org/10.1186/s40545-021-00327-6
19. Sangka P, Hongsamut D. Practices, interest, and preparedness of community pharmacists for improving the role of community pharmacy. J Heal Sci. 2010:19(6):982–995.
20. Nguyen HTT, Dinh DX, Nguyen VM. Knowledge, attitude and practices of community pharmacists regarding COVID-19: a paperbased survey in Vietnam. PLoS One. 2021;16(7):e0255420.
21. ElGeed H, Owusu Y, Abdulrhim S, et al. Evidence of community pharmacists’ response preparedness during COVID-19 public health crisis: a cross-sectional study. J Infect Dev Ctries. 2021;15(1):40-50.
22. Merks P, Religioni U, Bilmin K, et al. Readiness and willingness to provide immunization services after pilot vaccination training: a survey among community pharmacists trained and not trained in immunization during the covid-19 pandemic in Poland. Int J Environ Res Public Health. 2021;18(2):599.
23. Itani R, Karout S, Khojah HMJ, et al. Community pharmacists’ preparedness and responses to COVID-19 pandemic: a multinational study. Int J Clin Pract. 2021;75(9):e14421.
24. The National Health Security Office (2021). Every province will receive at least 40,000 antigen test kits. Available: https://eng. Accessed on 29 September 2021.
25. The National Health Security Office (2021). Available: DescriptionNews/Accessible-andaffordable- COVID-19-self-test-kits/422/EN-US.Accessible and affordable COVID-19 self-test kits. Accessed on 29 September 2021.
26. Kristina SA, Aditama H, Annisa M. Pharmacists’ willingness to administer COVID-19 vaccine: a survey from Yogyakarta community pharmacists. Pharm Sci Asia. 2022;9(3):217-222.
27. Gerges S, Gudzak V, Bowles S, et al. Experiences of community pharmacists administering COVID-19 vaccinations: a qualitative study. Cana Pharm J (Ott). 2023;156(1 Suppl):7S-17S.
28. Ibrahim OM, Ibrahim RM, Al Meslamani AZ, et al. Role of telepharmacy in pharmacist counselling to coronavirus disease 2019 patients and medication dispensing errors. J Telemed Telecare. 2020;29(1):18-27.
29. Dat TV, Tu VL, Quan NK, et al. Telepharmacy: a systematic review of field application, benefits, limitations, and applicability during the COVID-19 pandemic. Telemed J E Heal. 2023;29(2):209-221.
30. Unni EJ, Patel K, Beazer IR, et al. Telepharmacy during COVID-19: a scoping review. Pharmacy (Basel). 2021;9(4):183. https://
31. Muflih SM, Al-Azzam S, Abuhammad S, et al. Pharmacists’ experience, competence and perception of telepharmacy technology in response to COVID-19. Int J Clin Pract. 2021;75(7):e14209.
32. Margusino-Framiñán L, Fernández-Llamazares CM, Negro-Vega E, et al. Outpatients’ opinion and experience regarding telepharmacy during the COVID-19 pandemic: the Enopex Project. J Multidiscip Healthc. 2021;14:3621-3632. https://doi. org/10.2147/JMDH.S343528
33. Paudyal V, Fialová D, Henman MC, et al. Pharmacists’ involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy. Int J Clin Pharm. 2021;43(4):1139-1148.
34. Khojah HMJ, Itani R, Mukattash TL, et al. Exposure of community pharmacists to COVID-19: a multinational cross-sectional study. J Taibah Univ Med Sci. 2021;16(6):920-928.
35. Silva-Suárez G, Alvarado Reyes Y, Hernandez-Diaz A, et al. The voices of community pharmacists during the COVID-19 pandemic in Puerto Rico. J Am Pharm Assoc (2003). 2021;62(1):202-208.e3.
36. ALkharashi NA. The consumption of nutritional supplements and herbal products for the prevention and treatment of COVID-19 infection among the Saudi population in Riyadh. Clin Nutr Open Sci. 2021; 39:11-20. nutos.2021.09.001
37. Arora I, White S, Mathews R. Global dietary and herbal supplement use during COVID-19—a scoping review. Nutrients. 2023;15(3):771.
38. Zhu H, Li M, Tian C, et al. Efficacy and safety of Chinese herbal medicine for treating mild or moderate COVID-19: a systematic review and meta-analysis of randomized controlled trials and observational studies. Front Pharmacol. 2022;13:988237.
39. Ding X, Fan LL, Zhang SX, et al. Traditional Chinese medicine in treatment of COVID-19 and viral disease: efficacies and clinical evidence. Int J Gen Med. 2022;15:8353-8363.
40. Santos YS, de Souza Ferreira D, de Oliveira Silva ABM, et al. Global overview of pharmacist and community pharmacy actions to address COVID-19: a scoping review. Explor Res Clin Soc Pharm. 2023;10:100261.
41. Hoti K, Jakupi A, Hetemi D, et al. Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists’ experiences with preventative measures and sources of information. Int J Clin Pharm. 2020;42(4):1197-1206.
42. Yimenu DK, Demeke CA, Kasahun AE, et al. Impact of COVID-19 on pharmaceutical care services and the role of community pharmacists: a multi-center cross-sectional study in Ethiopia. SAGE Open Nurs. 2021;7:23779608211025804. https://doi. Org/10.1177/23779608211025804

Most read articles by the same author(s)